ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

NIH Challenge Grant Announcement

March 6, 2009

In Brief: Carcinogenesis Task Force to Wrap Up Review In Four-Six Weeks; UCLA Groundbreaking Set

October 28, 1977

Molecular target Drug Discovery Grants; Unanimously Approved

July 2, 1999

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999

Funding Opportunities

September 6, 2002